| 1 |
Agharazii M, St-Louis R, Gautier-Bastien A, et al. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification [J]. Am J Hypertens, 2015, 28(6): 746-755.
|
| 2 |
Bessueille L, Magne D. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes [J]. Cell Mol Life Sci, 2015, [Epub ahead of print]．
|
| 3 |
Farrokhi E, Samani KG, Chaleshtori MH. Oxidized low-density lipoprotein increases bone sialoprotein expression in vascular smooth muscle cells via runt-related transcription factor 2 [J]. Am J Med Sci, 2015, 349(3): 240-243.
|
| 4 |
Wu M, Rementer C, Giachelli CM. Vascular calcification: an update on mechanisms and challenges in treatment [J]. Calcif Tissue Int, 2013, 93(4): 365-373.
|
| 5 |
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification [J]. Postgrad Med, 2014, 126(2): 54-64.
|
| 6 |
张旭升，周小欧，黄战军，等．大鼠血管钙化模型炎症因子及其受体的表达[J]．岭南心血管病杂志，2013, 19(3): 341-345.
|
| 7 |
Tintut Y, Patel J, Parhami F, et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway [J]. Circulation, 2000, 102(21): 2636-2642.
|
| 8 |
Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification [J]? Circ Res, 2005, 96(12): 1248-1256.
|
| 9 |
Aoshima Y, Mizobuchi M, Ogata H, et al. Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α [J]. Nephrol Dial Transplant, 2012, 27(5): 1800-1806.
|
| 10 |
Dellegrottaglie S, Sanz J, Rajagopalan S．Molecular determinants of vascular calcification: a bench to bedside view[J]．Curr Mol Med, 2006, 6(5): 515-524.
|
| 11 |
Yamada S, Tokumoto M, Tatsumoto N, et al. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia[J]. Am J Physiol Renal Physiol, 2014, 306(12): F1418-1428.
|
| 12 |
Masuda M, Miyazaki-Anzai S, Levi M, et al. PERK-eIF2a-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification [J]. J Am Heart Assoc, 2013, 2(5): 238-252.
|
| 13 |
Marinelli A, Orlandi L, Stivali G. C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis [J]. Clinical Nephrology, 2011, 76(6): 425-434.
|
| 14 |
Ishimura E, Okuno S, Kitatani K, et al. C-reactive protein is a significant predictor of vascular calcif ication of both aorta and hand arteries [J]. Semin Nephrol, 2004, 24(5): 408-412.
|
| 15 |
Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization [J]. Nat Immunol, 2008, 9(8): 847-856.
|
| 16 |
Wen C, Yang X, Yan Z, et al. Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification [J]. Int J Cardiol, 2013, 168(3): 2242-2247.
|
| 17 |
彭利静，李慧，李超民，等．大鼠动脉钙化诱导过程中炎症小体复合物分子的变化[J]．生物技术通讯，2014, 25(3): 388-390.
|
| 18 |
Zhan JK, Tan P, Wang YJ, et al. Exenatide can inhibit calcification of human VSMCs through the NF-kappa B/RANKL signaling pathway [J]. Cardiovasc Diabetol, 2014, 13(1): 153.
|
| 19 |
Kang YH, Jin JS, Son SM. Long term effect of high glucose and phosphate levels on the OPG/RANK/RANKL/TRAIL system in the progression of vascular calcification in rat aortic smooth muscle cells [J]. Korean J Physiol Pharmacol, 2015, 19(2): 111-118.
|
| 20 |
Qin X, Corriere MA, Matrisian LM, et al. Matrix metalloproteinase inhibition aortic calcification [J]. Arterioscler Thromb Vasc Biol, 2006, 26(7): 1510-1516.
|
| 21 |
Couchourel D, Aubry I, Delalandre A, et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production [J]. Arthritis Rheum, 2009, 60(5): 1438-1450.
|
| 22 |
彭朝胜，曹悦鞍．胎球蛋白-A与动脉钙化[J]．海军总医院学报，2010, 23(1): 29-32.
|
| 23 |
Callegari A, Coons ML, Ricks JL, et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-κB ligand and interleukin 6 [J]. Vasc Res, 2014, 51(2): 118-131.
|
| 24 |
Ikeda K, Souma Y, Akakabe Y, et al. Macrophages play a unique role in the plaque calcification by enhancing the osteogenic signals exerted by vascular smooth muscle cells [J]. Biochem Biophys Res Commun, 2012, 425(1): 39-44.
|
| 25 |
Lee CT, Tsai YC, Su CY, et al. Interleukin 10 and residual kidney function are associated with risk of vascular calcification in patients undergoing peritoneal dialysis [J]. Clinical Nephrology, 2011, 75(5): 397-402.
|
| 26 |
赵安菊，黄颂敏，欧三桃，等．Cbfα-1和MCP-1在DN大鼠肾内小动脉中表达意义及相关性研究[J]．中国现代医学杂志，2011, 21(33): 4109-4113.
|
| 27 |
Fuchs S, Lavi I, Tzang O, et al. Intracoronary monocyte chemoattractant protein 1 and vascular endothelial growth factor levels are associated with necrotic core, calcium and fibrous tissue atherosclerotic plaque components: an intracoronary ultrasound radiofrequency study [J]. Cardiology, 2012, 123(2): 125-132.
|
| 28 |
Guerrero F, Montes de Oca A, Aguilera-Tejero E, et al. The effect of vitamin D derivatives on vascular calcification associated with inflammation [J]. Nephrol Dial Transplant, 2012, 27(6): 2206-2212.
|